CSN3 and central nervous system cancer: The limma package and univariate Cox regression indicated that the 14 validated DRGs did not only manifest significantly different expressions between tumors and normal + para tumor tissues, but they could also predict differential survival in glioma, KCA, KIRC, MESO, and UVM (Figures 1C, E).